Biotech

All Articles

GSK goes down ph. 2 HPV injection over lack of best-in-class possible

.GSK has junked a stage 2 individual papillomavirus (HPV) injection from its own pipe after determin...

OS Treatments refiles $6M IPO to fund HER2 drug, preclinical ADCs

.Operating system Therapies will certainly note on the NYSE American stock exchange this morning usi...

ALX's fizzling CD47 response cost delivers sell spiraling down

.ALX Oncology's stage 2 gastric cancer cells reaction rate has actually compromised. After finding i...

Ionis axes eye health condition coming from aim ats of Roche-partnered possibility after records disappoint

.Another of Ionis Pharmaceuticals' key midphase readouts has actually disappointed assumptions, cuin...

Biogen's chief executive officer claimed no unsafe deals in 2023. He prepares to be strong

.While Biogen's pharma peers are looking for late-stage possessions along with little bit of threat,...

Instil refills pipe in $2B biobucks handle ImmunOnco

.Instil Biography has been a biotech looking for a pipeline after it junked its own lead assets over...

Biogen walks away from Denali Alzheimer's collab

.Biogen has returned liberties to an early Alzheimer's condition program to Denali Therapies, going ...

Takeda water faucets brand-new mind people oncology service-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of significant management hirings, shootings and...

Vertex, hammered through AATD again, drops 2 possessions on discard stack

.Vertex's try to alleviate a rare hereditary health condition has hit another setback. The biotech t...

Vir increases 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Biotechnology's second-quarter incomes file had not been except major information. The firm wel...